MEDTR vs GUBRF Comparison
Price, market cap, valuation, profitability and leverage metrics of MEDTR and GUBRF side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | MEDTR | GUBRF | Sector median |
|---|---|---|---|
| Last price (TL) | 18.27 | 436.00 | 18.72 |
| Daily change | −5.82% | −4.80% | −5.85% |
| Market cap | TRY 2.2B | TRY 145.6B | TRY 4.3B |
| P/E | 66.43 | 19.22 | 17.35 |
| P/B | 0.69 | 3.89 | 1.09 |
| Dividend yield | 0.44% | — | 0.90% |
| Return on equity | 1.14% | 23.87% | 1.78% |
| Free float | 20.21% | 20.28% | 37.21% |
Popular Comparisons
Related Pages
About the MEDTR vs GUBRF Comparison
Price, market cap, valuation multiples, profitability and leverage of MEDTR (Meditera Tibbi Malzeme) and GUBRF (Gübre Fabrik.) side by side as of Sep 28, 2026, 13:47. Of the 14 metrics compared, MEDTR leads in 7 and GUBRF leads in 7.
Highlights: Daily change: GUBRF leads (−4.80% vs −5.82%). Market cap: GUBRF leads (TRY 145.6B vs TRY 2.2B). P/E: GUBRF leads (19.22 vs 66.43). P/B: MEDTR leads (0.69 vs 3.89). EV/EBITDA: MEDTR leads (7.60 vs 11.70). EV/Sales: MEDTR leads (1.36 vs 3.90). Gross margin: MEDTR leads (33.71% vs 26.69%). EBITDA margin (annual): GUBRF leads (22.84% vs 3.58%).
Frequently Asked Questions
Is MEDTR or GUBRF cheaper?
By P/E, GUBRF is cheaper (66.43 vs 19.22); by P/B, MEDTR trades at the lower multiple (0.69 vs 3.89).
Which is more profitable, MEDTR or GUBRF?
Annual net margin is 1.35% for MEDTR and 13.44% for GUBRF; return on equity is 1.14% for MEDTR and 23.87% for GUBRF.
Which is more leveraged, MEDTR or GUBRF?
The leverage ratio is 15.79 for MEDTR and 41.50 for GUBRF; net debt/EBITDA is — for MEDTR and −0.39 for GUBRF. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.